Cure Parkinson’s and Alzheimer’s Research UK announce a partnership
Cure Parkinson’s and Alzheimer’s Research UK are working on an initiative that could pave the way for innovative neurodegenerative treatments. There is a growing recognition that tackling neurodegenerative diseases could benefit from a collaborative, cross-disease approach. We are recognising the overlap in underlying biological...
Learn more
Further data on the relationship between diabetes and Parkinson’s
New research has found that there is convincing evidence that Type 2 diabetes is associated with a greater risk of Parkinson’s, but may in turn allow for better management of the disease.
Rheumatoid arthritis and Parkinson’s
Recently, researchers have asked whether there is an association between Parkinson’s and rheumatoid arthritis: Could people with rheumatoid arthritis be at higher risk of developing Parkinson’s?
COVID-19 and the need for remote clinical trials
Whilst the COVID pandemic has dealt a cruel blow to current Parkinson’s research efforts, it has served as an opportunity for innovation and improvement, and this is particularly so in the way some clinical trials are being organised.
More data from the ‘Blue Rockers’
BlueRock Therapeutics has published two preclinical research reports outlining the cell culturing method that they are taking into clinical trials.
Parkinson’s and pesticides
Much of our focus is on treatments, but treatments are only part of the story. A vital step for Cure Parkinson’s is to stop people from getting Parkinson’s in the first place. Read more about taking action against pesticide use.